By combining two complementary peptides, this formulation has become a significant focus of research involving recovery, body composition, cellular repair, and healthy aging
It formally characterises DSIP as a still unresolved riddle acknowledging that no specific DSIP receptor has been confirmed, that the existence of DSIP-like endogenous peptides distinct from DSIP itself may account for a substantial proportion of DSIP-like immunoreactivity data, and that the most robust SWS-promoting activity in rodent studies has been demonstrated for synthetic DSIP structural analogues rather than native DSIP itself
Oleksiak MF, Churchill GA, Crawford DL
For reference, tesamorelin's FDA label dose alone is 2 mg/day (or 1.28 mg/day for the EGRIFTA WR formulation), and ipamorelin has been studied around 100-300 mcg per dose
Molecules 25(22):5342 Ross AC (2010) Vitamin A
Is Gastroparesis Reversible